In a new study released this week, treatment with radiolabeled monoclonal antibody Bexxar® (Tositumomab and Iodine I 131 Tositumomab) following fludarabine chemotherapy produced responses in 100 percent of patients (n=35) with previously untreated low-grade/follicular non-Hodgkin's lymphoma (NHL), and 86 percent of patients (n=30) achieved a complete response. The single-site study was conducted at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and published in the August 20, 2005, issue of The Journal of Clinical Oncology.

For years, the "gold standard" treatment for patients struggling with posttraumatic stress disorder (PTSD) has involved exposure to reminders of the triggering traumatic event. Now, findings from a small pilot study by Weill Cornell Medical College researchers may offer patients a new alternative to that often painful process.

Refuting recent claims that the era of the prostate-specific antigen (PSA) test is over, physician-scientists at Columbia University Medical Center and NewYork-Presbyterian Hospital presented a study demonstrating that pre-operative PSA is an accurate measure of cancer recurrence. The study was presented today at the annual meeting of the American Urological Association (AUA) in San Antonio, Texas.

One of the nation's leading prostate cancer specialists, Dr. Mitchell C. Benson has been appointed Chairman of the Department of Urology at Columbia University College of Physicians and Surgeons (P&S) and Urologist-in-Chief at NewYork-Presbyterian Hospital/Columbia. Dr. Benson is the George F. Cahill Professor of Urology at P&S, a professorship established in 1957 to honor the former chairman of the Department of Urology. He is also attending physician and Director of Urologic Oncology at NewYork-Presbyterian/Columbia.

In a successful procedure today at NewYork-Presbyterian Hospital/The Allen Pavilion, a robot for the first time functioned as an independent assistant to the surgical team by handing and retrieving surgical instruments. The robot performed all of its assigned functions properly, a key validation of this important new technology and a dramatic demonstration of the potential for automation in the operating room.

Addressing a substantial need for mental and behavioral health care evaluation and treatment, elementary school students are treated by specialists onsite at 11 elementary schools in Washington Heights, Inwood, and Central Harlem, as part of the School-Based Mental Health Programs provided by the Pediatric Psychiatry Service at Morgan Stanley Children's Hospital of NewYork-Presbyterian. The programs are conducted in concert with the New York City Department of Education and the New York City Department of Health and Mental Hygiene, and receive support from several local foundations. Beginning in July, the programs will be expanded to serve approximately 625 children at 13 school sites.

Understanding the genetic origins and complications of urinary tract abnormalities is among the research investigations of Dr. Cathy Lee Mendelsohn, a developmental biologist.

Over the past 15 years, pediatric urologists have been utilizing the Da Vinci robotic surgical platform to facilitate minimally invasive surgery in children and infants. Learn how this technique has revolutionized the field.